4//SEC Filing
Klichinsky Michael 4
Accession 0001104659-24-010107
CIK 0001485003other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:53 PM ET
Size
5.7 KB
Accession
0001104659-24-010107
Insider Transaction Report
Form 4
Klichinsky Michael
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-31+170,500→ 170,500 totalExercise: $2.10Exp: 2034-01-31→ Common Stock (170,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.
Documents
Issuer
Carisma Therapeutics Inc.
CIK 0001485003
Entity typeother
Related Parties
1- filerCIK 0001967221
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:53 PM ET
- Size
- 5.7 KB